Published in J Interv Card Electrophysiol on March 01, 2001
Management of atrial fibrillation--what are the possibilities of early detection with home monitoring? Clin Res Cardiol (2006) 1.17
Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature. Heart (2004) 0.84
The worldwide social burden of atrial fibrillation: what should be done and where do we go? J Interv Card Electrophysiol (2007) 0.84
Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation. J Interv Card Electrophysiol (2004) 0.82
The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough? J Interv Card Electrophysiol (2003) 0.77
Is dual defibrillator better than conventional DDD pacing in brady-tachy syndrome? Results of the ICARUS Trial (Internal Cardioversion Antitachypacing and Prevention: Resource Utilization Study). J Interv Card Electrophysiol (2006) 0.76
Hybrid therapy of atrial fibrillation: algorithms and outcome. J Interv Card Electrophysiol (2003) 0.75
Atrial fibrillation and pacing algorithms. Indian Pacing Electrophysiol J (2006) 0.75
Rationale and patient selection for "hybrid" drug and device therapy in atrial and ventricular arrhythmias. J Interv Card Electrophysiol (2003) 0.75
Atrial overdrive pacing and incidence of heart failure-related adverse events in permanently paced patients. J Interv Card Electrophysiol (2007) 0.75
[The role of cardiac pacing in atrial arrhythmia prevention]. Z Kardiol (2005) 0.75
Atrial fibrillation: profit from cardiac pacing? Z Kardiol (2005) 0.75
The role of pacing in rhythm control and management of atrial fibrillation. J Interv Card Electrophysiol (2007) 0.75
Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet (1997) 3.34
Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J (1988) 3.33
Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol (1996) 2.27
Sinus node automaticity during atrial fibrillation in isolated rabbit hearts. Circulation (1992) 2.21
Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol (1999) 1.68
Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol (1998) 1.67
The natural history of sick sinus syndrome. Pacing Clin Electrophysiol (1986) 1.65
Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol (1992) 1.53
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace (1999) 1.41
Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation (1993) 1.25
Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol (1990) 1.13
A new pacing algorithm for overdrive suppression of atrial fibrillation. Chorus Multicentre Study Group. Pacing Clin Electrophysiol (1994) 1.00
Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin Electrophysiol (1998) 0.96
Ventricular pacing for sick sinus syndrome--a risky business? Pacing Clin Electrophysiol (1990) 0.92
Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. Am J Cardiol (1999) 0.90
Influence of cardiac pacing mode on the long-term development of atrial fibrillation. Am J Cardiol (1989) 0.89
Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol (1990) 0.89
Pacing in sick sinus syndrome--need for a prospective, randomized trial comparing atrial with dual chamber pacing. Pacing Clin Electrophysiol (1998) 0.84
Multisite or alternate site pacing for the prevention of atrial fibrillation. Am J Cardiol (1999) 0.83
Pacing strategies to prevent atrial fibrillation. Cardiol Clin (1996) 0.79
Rate augmentation and atrial arrhythmias in DDDR pacing. Pacing Clin Electrophysiol (1990) 0.78
Long-term haemodynamic and antiarrhythmic benefits of DDIR versus DDI pacing mode in sick sinus syndrome and chronotropic incompetence. G Ital Cardiol (1997) 0.78
Non-pharmacological treatment of supraventricular arrhythmias. Eur Heart J (1996) 0.77
Sinus node during atrial fibrillation. To beat or not to beat? Circulation (1992) 0.77
Is rate response superior to single rate pacing in atrial arrhythmia control? Europace (1999) 0.77
Reliability of a new algorithm for automatic mode switching from DDDR to DDIR pacing mode in sinus node disease patients with chronotropic incompetence and recurrent paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (1996) 0.77
Atrial premature beats preceding episodes of paroxysmal atrial fibrillation: factorial analysis of a prediction system. Pacing Clin Electrophysiol (1997) 0.75
Mechanisms of pacing interventions in atrial fibrillation. J Cardiovasc Electrophysiol (1998) 0.75
Pacing therapy for atrial tachyarrhythmias. Clin Cardiol (1996) 0.75
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med (2001) 9.68
Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation (1997) 5.16
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04
Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. Eur Heart J (2002) 2.75
Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol (1998) 2.38
Diagnosing syncope in clinical practice. Implementation of a simplified diagnostic algorithm in a multicentre prospective trial - the OESIL 2 study (Osservatorio Epidemiologico della Sincope nel Lazio) Eur Heart J (2000) 2.02
Influence of digital and analogue cellular telephones on implanted pacemakers. Eur Heart J (1997) 1.82
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J (2004) 1.66
Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol (1992) 1.66
Myotonic dystrophy and the heart. Heart (2002) 1.61
Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J (2002) 1.59
Radiofrequency catheter ablation of idiopathic left ventricular outflow tract tachycardia: utility of intracardiac echocardiography. J Cardiovasc Electrophysiol (2001) 1.57
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
Characteristics and distribution of spinal focal synaptic potentials generated by group II muscle afferents. Acta Physiol Scand (1974) 1.47
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
Improving feasibility of posterior descending coronary artery flow recording by transthoracic Doppler echocardiography. Eur J Echocardiogr (2003) 1.45
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J (2002) 1.45
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Electroencephalographic correlates of vasovagal syncope induced by head-up tilt testing. Stroke (1998) 1.42
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace (1999) 1.41
Gemcitabine and small cell lung cancer. Lung Cancer (2001) 1.40
Biventricular pacing in patients with heart failure and intraventricular conduction delay: state of the art and perspectives. The European view. Eur Heart J (2002) 1.39
Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation. Heart (2011) 1.39
[Diagnostic contribution of magnetic resonance in clinically suspected arrhythmogenic dysplasia of the right ventricle]. G Ital Cardiol (1996) 1.39
Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation (2001) 1.32
Convergence on interneurones mediating the reciprocal Ia inhibition of motoneurones. I. Disynaptic Ia inhibition of Ia inhibitory interneurones. Acta Physiol Scand (1976) 1.29
Doppler myocardial imaging in patients with heart failure receiving biventricular pacing treatment. Am Heart J (2001) 1.28
Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood (1991) 1.23
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation (2001) 1.18
Management of atrial fibrillation--what are the possibilities of early detection with home monitoring? Clin Res Cardiol (2006) 1.17
A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure. Am Heart J (1999) 1.17
[Cutaneous necrotizing vasculitis caused by immunocomplexes during treatment with levamisole]. Boll Ist Sieroter Milan (1983) 1.14
The World Survey of Cardiac Pacing and Implantable Cardioverter Defibrillators: calendar year 1997--Europe. Pacing Clin Electrophysiol (2001) 1.13
Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet (2003) 1.13
Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12
Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry (2001) 1.12
The value of permanent follow-up of implantable pacemakers--first results of an European trial. Biomed Tech (Berl) (2002) 1.10
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol (1994) 1.09
Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J (2001) 1.09
Variable cerebral dysfunction during tilt induced vasovagal syncope. Pacing Clin Electrophysiol (1998) 1.08
Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest (1991) 1.06
[Guidelines for the use of the implantable defibrillator. Combined task force of the Italian Group of Arrhythmia and the Italian Association of Cardiostimulation]. G Ital Cardiol (1992) 1.06
Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator. Participating Investigators of ICD-HRV Italian Study Group. Am J Cardiol (2000) 1.06
Do European GSM mobile cellular phones pose a potential risk to pacemaker patients? Pacing Clin Electrophysiol (1995) 1.05
The fine structure of the sympathetic axons within the Pacinian corpuscle. Brain Res (1971) 1.03
Convergence on interneurones mediating the reciprocal Ia inhibition of motoneurones. III. Effects from supraspinal pathways. Acta Physiol Scand (1976) 1.02
Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol (2011) 1.01
Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure. Am J Cardiol (1998) 1.01
Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol (1996) 1.01
Stroke, disability, and dementia: results of a population survey. Stroke (1997) 1.00
Short-term sacral nerve stimulation for functional anorectal and urinary disturbances: results in 40 patients: evaluation of a new option for anorectal functional disorders. Dis Colon Rectum (2001) 0.99
Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry (2009) 0.99
Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol (1994) 0.99
Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation (1995) 0.99
Hyperpolarizing increase in membrane conductance in hippocampal neurons. Brain Res (1968) 0.99
Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function. Am Heart J (2001) 0.98
Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey. Europace (2007) 0.98
Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. Int J Cardiol (1992) 0.97
Pebbles and PebbleJuggler: software for accurate, unbiased, and fast measurement and analysis of nanoparticle morphology from transmission electron microscopy (TEM) micrographs. Nanoscale (2012) 0.97
Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (1999) 0.96
Management of patients with syncope referred urgently to general hospitals. Europace (2003) 0.96
The fine structure of thin unmyelinated axons within muscle spindles. Brain Res (1971) 0.95
Gasless video-assisted reversal of Hartmann's procedure. Surg Endosc (1995) 0.94
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med (1997) 0.94
Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence. Heart (2004) 0.94
Neuromodulation for fecal incontinence: outcome in 16 patients with definitive implant. The initial Italian Sacral Neurostimulation Group (GINS) experience. Dis Colon Rectum (2001) 0.93
Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol (1995) 0.92
Electrophysiological basis for arrhythmias caused by acute ischemia. Role of the subendocardium. J Mol Cell Cardiol (1986) 0.92
Effect of bunaphtine on right atrial repolarisation in man. Br Heart J (1977) 0.92
Melanoma epidemic across the millennium: time trends of cutaneous melanoma in Emilia-Romagna (Italy) from 1997 to 2004. J Eur Acad Dermatol Venereol (2008) 0.92
Spinal cord stimulation in patients with refractory anginal pain and normal coronary arteries. Ital Heart J (2001) 0.92
Convergence on interneurones mediating the reciprocal Ia inhibition of motoneurones. II. Effects from segmental flexor reflex pathways. Acta Physiol Scand (1976) 0.92
Ventricular cross stimulation in a dual chamber pacing system: phenomenon analysis. Pacing Clin Electrophysiol (1990) 0.91
Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J (1997) 0.91
Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91
Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation (1999) 0.89